-
[Memory diseases].
Sellal F, Weiss C. Rev Prat. 2023 Dec;73(10):1081-1084.
-
Medical demography at stroke centers: Current situation in France.
Sablot D, Touzé E, Ellie E, Alamowitch S, De Broucker T, Guillon B, Sellal F, Crozier S, Sibon I. Rev Neurol (Paris). 2024 Mar;180(3):171-176. doi: 10.1016/j.neurol.2023.08.012. Epub 2023 Oct 23.
-
Epileptic Prodromal Alzheimer’s Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
Hautecloque-Raysz G, Sellal F, Bousiges O, Phillipi N, Blanc F, Cretin B. J Alzheimers Dis. 2023;94(3):1057-1074. doi: 10.3233/JAD-221197.
-
Letter and Category Fluency: Normative Data for Lebanese Older Adults.
El-Hayeck R, Wehbé A, Baddoura R, Khoury R, Bassil N, Abou Khaled K, Koussa S, Richa S, Alameddine A, Sellal F.J Alzheimers Dis. 2023;93(1):321-332. doi: 10.3233/JAD-221121.PMID: 37005886
-
Anatomical and neurophysiological basis of face recognition.
Sellal F. Rev Neurol (Paris). 2022 Sep;178(7):649-653. doi: 10.1016/j.neurol.2021.11.002. Epub 2021 Dec 1.
-
Multifocal and Microvascular Involvement in Ischemic Stroke During COVID-19: A Cohort Study With Comparison With Non-COVID-19 Stroke.
Hautecloque G, Kempf C, Stan C, Arentz-Dugay MH, Vuillemet F, Ahle G, Sellal F, Martinot M.Front Neurol. 2021 Oct 25;12:732194. doi: 10.3389/fneur.2021.732194. eCollection 2021.PMID: 34759880
-
CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
Ungureanu A, Le Garff-Tavernier M, Costopoulos M, Parratte T, Brinet A, Durand H, Gaultier C, Hurstel R, Alamome I, Sellal F, Ahle G.J Neurol. 2021 Aug;268(8):2890-2894. doi: 10.1007/s00415-021-10453-5. Epub 2021 Feb 20.PMID: 33609156
-
Commotion cérébrale en pratique sportive.
Ellie E. Rev Prat 2026 40(1108);287-90
-
The Babinski sign in Renaissance paintings-a reappraisal of the toe phenomenon in representations of the Christ Child: observational analysis.
Sellal F, Tatu L. BMJ. 2020 Dec 10;371:m4556. doi: 10.1136/bmj.m4556.
-
Cognitive Impairment and Brain Metabolic Changes in Post-Acute Sequelae of COVID-19: Insights From an [ 18 F]FDG PET/CT Cohort Study.
Rozenblum L, Debroucker T, Habert MO, Soret M, Desarnaud S, Lemercier VC, Guedj E, Marshall E, Salmon D, Kas A. Clin Nucl Med. 2025 Mar 1;50(3):e146-e153. doi: 10.1097/RLU.0000000000005614. Epub 2024 Dec 18. PMID: 39690505